Cysteine residues 86 and 91 of the ␤ subunit of the human interleukin (hIL)-3 receptor (h␤c) participate in disulfide-linked receptor subunit heterodimerization. This linkage is essential for receptor tyrosine phosphorylation, since the Cys-86 3 Ala (Mc4) and Cys-91 3 Ala (Mc5) mutations abolished both events. Here, we used these mutants to examine whether disulfide-linked receptor dimerization affects the biological and biochemical activities of the IL-3 receptor. Murine T cells expressing hIL-3R␣ and Mc4 or Mc5 did not proliferate in hIL-3, whereas cells expressing wild-type h␤c exhibited rapid proliferation. However, a small subpopulation of cells expressing each mutant could be selected for growth in IL-3, and these proliferated similarly to cells expressing wild-type h␤c, despite failing to undergo IL-3-stimulated h␤c tyrosine phosphorylation. The Mc4 and Mc5 mutations substantially reduced, but did not abrogate, IL-3-mediated anti-apoptotic activity in the unselected populations. Moreover, the mutations abolished IL-3-induced JAK2, STAT, and AKT activation in the unselected cells, whereas activation of these molecules in IL-3-selected cells was normal. In contrast, Mc4 and Mc5 showed a limited effect on activation of Erk1 and -2 in unselected cells. These data suggest that whereas disulfide-mediated cross-linking and h␤c tyrosine phosphorylation are normally important for receptor activation, alternative mechanisms can bypass these requirements.
the hematopoietin receptor superfamily, often termed the cytokine receptor family. The high affinity GM-CSF⅐IL-3⅐IL-5 receptor complexes are composed of specific ␣ chains that bind GM-CSF⅐IL-3⅐IL-5 with low affinity (1-3) and a common ␤ chain (␤c) that converts the binding to high affinity by forming a heterodimer with the ␣ subunit (4) . The oligomerization of ␣ and ␤ subunits mediated by ligand binding is thought to initiate signal transduction.
It is generally accepted that whereas the cytoplasmic domains of both ␣ and ␤ subunits are required for receptor activation, in some cases dimerization of the cytoplasmic domain of the ␤ subunit alone is sufficient. This was demonstrated by a study in which a chimeric receptor consisting of the extracellular domain of the erythropoietin receptor and the intracellular domain of ␤c or ␤ IL-3 was constructed. Erythropoietin induced proliferation signals in Ba/F3 cells through the chimeric receptors, indicating that the homodimerization of the ␤ subunit is sufficient for receptor activation (5) . Likewise, a mutant GM-CSF receptor ␣ chain (GM-CSFR␣), in which the cytoplasmic domain was replaced with that of the ␤c, formed a high affinity receptor with the normal ␤c and transduced proliferative signals, again indicating the importance of the dimerization of the ␤ cytoplasmic domain (6) . In contrast, the ␤c mutant in which the cytoplasmic domain was substituted with that of GM-CSFR␣ forms a high affinity GM-CSFR with the GM-CSFR␣ but was unable to induce a proliferation signal, indicating that the dimerization of the GM-CSFR␣ cytoplasmic domain was not sufficient for signaling (6) .
Despite the lack of an intrinsic tyrosine kinase in the receptors, GM-CSF, IL-3, and IL-5 induce rapid tyrosine phosphorylation of various cellular proteins, including the ␤ subunits themselves. It is now known that cytoplasmic JAK family tyrosine kinases associate with the ␤ subunit via conserved membrane proximal regions known as "box-1" and "box-2" (7, 8) . The activated JAK kinases phosphorylate tyrosine residues of many signaling proteins, among which are the latent cytoplasmic transcription factors known as signal transducer and activator of transcription (STAT). The activation of JAKs and/or STATs is important for many if not all activities of cytokine receptors (7, 9, 10) .
The Ras-Raf-MAP kinase pathway is another major signaling pathway activated in response to GM-CSF and IL-3 (11) (12) (13) . It has been demonstrated that a membrane-distal region of ␤c is required for activation of the Ras-Raf-MAP kinase pathway (11) . Circumstantial evidence implies that JAK2 is also required for activation of this pathway by IL-3 and GM-CSF. Deletion of the box-1 region in ␤c (which is believed to be the site of JAK2 association with ␤c) or expression of a dominant negative form of JAK2 prevented phosphorylation of molecules involved in Ras activation (Shc and SHP2) (7) . Moreover, these same manipulations also blocked IL-3/GM-CSF-induced activation of the c-fos promoter (7, 14) , which is also blocked by dominant negative Ras (14) . This pathway may also be important for cell survival (15-17) (see also "Discussion").
Signaling pathways that promote cell survival also include the phosphatidylinositide-3Ј-OH kinase (PI3K)-AKT pathway. The AKT kinase is a general mediator of cytokine-induced survival and has been shown to suppress the apoptotic death of a number of cell types induced by a variety of stimuli, including growth factor withdrawal, cell cycle discordance, loss of cell adhesion, and DNA damage (18 -21) . Thus, a signaling pathway has been defined in which cytokine receptor activation leads to the sequential activation of PI3K and AKT, which then promotes cell survival and blocks apoptosis.
Our previous study (22) showed that Cys-86 and Cys-91 but not other Cys residues of human ␤c (h␤c) participated in disulfide-linked receptor subunit heterodimerization. We also showed that this linkage is essential for receptor phosphorylation because alanine substitutions of residues 86 (termed Mc4) and 91 (Mc5), but not 100 (Mc7), abolished not only IL-3-induced disulfide-linked IL-3 receptor subunit dimerization but also tyrosine phosphorylation of h␤c, without affecting IL-3 binding. To investigate whether or not disulfide-mediated cross-linking of IL-3 receptor subunits and phosphorylation of h␤c are essential for receptor signaling, we have now examined the effects of these cysteine mutations on biological and biochemical activities of the IL-3 receptor when expressed in the murine T cell line CTL-EN. We have found that h␤c mutants Mc4 and Mc5 barely induce cell proliferation compared with wild-type (WT) or Mc7. Interestingly, a subpopulation of cells expressing each of the former mutants could be selected for growth in IL-3, which, despite the absence of detectable h␤c tyrosine phosphorylation, proliferated at similar rates to cells expressing WT h␤c. Our data also show that Mc4 and Mc5 (but not Mc7) impaired IL-3-facilitated protection against apoptosis and failed to induce IL-3-stimulated JAK2, STAT, and AKT activation in unselected cells. However, Mc4 and Mc5 had a less severe effect on IL-3-induced Erk1/2 MAP kinase activation in the unselected cells. In contrast, in the IL-3-selected cells, the cysteine mutations had no effects on IL-3-induced activation of any of the signaling molecules that we examined.
EXPERIMENTAL PROCEDURES
Cell Culture-The ecotropic 2 retrovirus packaging cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal calf serum (FCS), 2 mM L-glutamine, and antibiotics. The IL-2-dependent mouse T cell line, CTL-EN (a derivative of CTLL-2, described in Ref. 23) , was maintained in CTLL medium (DMEM supplemented with 10% FCS, 2 mM L-glutamine, antibiotics, 50 M ␤-mercaptoethanol, 5% conditioned medium from MLA cells, and 100 units/ml bacterially synthesized mouse IL-2.
Construction of Expression Plasmids-Cysteine mutants Mc4, Mc5, Mc7, or WT h␤c cDNAs (22) were inserted between the BamHI and HpaI restriction sites of the pRufHygro retroviral vector. The pRufHygro retroviral vector was constructed by replacing the MC1Neo cassette of pRufNeo (24) with a phosphoglycerate kinase/hygromycin resistance cassette from pPGKHygro (25) .
Transfection and Infection Procedures-The ecotropic packaging cell line 2 was transfected by a standard calcium phosphate transfection procedure as described (26) with 10 g of retroviral plasmid containing WT or cysteine mutant h␤c per 10-cm dish. After overnight incubation the cells were shocked with 2.5 ml of 15% glycerol in DMEM for 4 min followed by a further 24 h incubation and then selected in hygromycin (Roche Molecular Biochemicals) at 200 g/ml. The selected cells were sorted for expression of h␤c, and collected in DMEM. These sorted 2 cells expressing WT or the cysteine mutant h␤c were then used to infect CTL-EN cells previously infected with a pRUFNeo retrovirus vector (24) encoding the ␣ chain of human IL-3 receptor (hIL-3R␣), using procedures described previously (26) . The infected CTL-EN cells were selected in hygromycin at 600 g/ml, and expression of WT or cysteine mutant h␤c on the surface of the hygromycin-resistant cells was examined by flow cytometry.
Cell Sorting and Analysis of Receptor Subunit Expression by Flow Cytometry-Cells expressing WT or cysteine mutant h␤c were collected by cell sorting on a FACStar PLUS flow cytometer (Coulter, Hialeah, FL). Briefly, cells were washed and resuspended in cold DMEM supplemented with 5% FCS. Cells were incubated with the anti-h␤c monoclonal antibody 8B8 (27) for 20 min on ice, washed, and subsequently incubated with fluorescein isothiocyanate-conjugated anti-mouse IgG (Silenus, Hawthorn, Victoria, Australia) for 20 min on ice. After washing and resuspension in medium, the cells were sorted, and the positive cells collected in CTLL medium.
Radiolabeling of Human IL-3 and Binding Assays-The procedures used for radiolabeling of human IL-3 with 125 I and performing saturation-binding assays have been described previously (28, 29) .
Cell Proliferation Assays-Infected CTL-EN cells expressing hIL-3R␣ and WT or cysteine mutant h␤c were washed three times with PBS, and triplicate samples of 5 ϫ 10 3 cells were cultured in a 96-well microtiter plate with or without IL-3 for 72 h. Cell proliferation was measured by the CellTiter 96 Non-Radioactive Cell Proliferation Assay (Promega, Madison, WI). The data were normalized with respect to proliferation of the same cells cultured in 100 units/ml of IL-2.
Apoptosis Assays-Apoptotic cells were detected using the Annexin-V-Fluos Staining kit (Roche Molecular Biochemicals) as per manufacturer's instructions. Briefly, cells (5 ϫ 10 5 ) were washed with PBS and centrifuged at 2,000 ϫ g for 5 min. The cell pellets were resuspended in 100 l of labeling solution (1:50 diluted Annexin-V-Fluos labeling reagent in 10 mM HEPES buffer (pH 7.4) and 1 g/ml of propidium iodide) and then added to 0.4 ml of incubation buffer (10 mg of HEPES (pH 7.4), 140 mM NaCl, 5 mM CaCl 2 ). The cells were analyzed on a flow cytometer using a 488-nm excitation and a 515-nm band pass filter.
Immunoprecipitation-CTL-EN cells coexpressing hIL-3R␣ and WT or cysteine mutant h␤c (4 ϫ 10 7 ) were cultured overnight in the absence of cytokines. Cells were washed with cold PBS followed by stimulation at 37°C for 5-15 min as indicated with varying concentrations of IL-3 (0 -10 ng/ml) and then lysed on ice in lysis buffer (50 mM HEPES (pH 7.5), 150 mM NaCl, 10% glycerol, 1% Nonidet P-40, 0.1% SDS, 0.1% sodium deoxycholate 2 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride, 1 mM EDTA, 1 mM EGTA, 2 mg/ml iodoacetamide, 50 mM sodium fluoride, 10 mM sodium pyrophosphate, 0.2 mg/ml trypsin inhibitor (Roche Molecular Biochemicals) and Complete TM protease inhibitor (Roche Molecular Biochemicals)) for 15 min. Insoluble materials were removed by centrifugation, and cell lysates were incubated with rabbit anti-JAK2 antibody 2 or anti-h␤c monoclonal antibody 8E4 (30) for 2 h at 4°C. Immune complexes were precipitated with 75 l of protein A-Sepharose (Amersham Pharmacia Biotech) for 90 min at 4°C, washed twice with lysis buffer, and boiled in 1ϫ reducing SDS loading buffer.
2 T. J. Blake and T. J. Gonda, unpublished data. Western Blotting-Immunoprecipitates, or cell lysates prepared as described above, were separated by SDS-polyacrylamide gel electrophoresis and electrophoretically transferred to Protran R nitrocellulose transfer membranes (Schleicher & Schuell). Membranes were incubated with a blocking solution (3% bovine serum albumin in TBS-T (50 mM Tris-HCl (pH 7.4), 135 mM NaCl and 0.1% Tween 20)) at room temperature for 1 h and then incubated overnight with antibody in the same solution at 4°C. The antibodies used were anti-JAK2 (as above); anti-phosphotyrosine (4G10; Upstate Biotechnology, Inc., Lake Placid, NY); anti-h␤c (1C1; Ref. 28); anti-Erk1/2 (Zymed Laboratories Inc., San Francisco, CA); anti-phospho-Erk1/2 (Promega, Madison, WI); and antiphospho-AKT and anti-AKT (Santa Cruz Biotechnology, Santa Cruz, CA). The membranes were then washed three times in TBS-T solution and incubated with anti-mouse or anti-rabbit secondary antibodies (as appropriate) coupled with horseradish peroxidase (Pierce). Membranes were washed in TBS-T three times and subjected to enhanced chemiluminescence detection as per the manufacturer's instructions (Pierce). Before reprobing, membranes were stripped in 50 mM Tris (pH 7.4), 2% SDS, 100 mM ␤-mercaptoethanol at 55°C for 10 mim, washed three times in TBS-T, and blocked in TBS-T containing 3% bovine serum albumin.
Electrophoretic Mobility Shift Analysis (EMSA) of STATs-Nuclear extracts from CTL-EN cells expressing hIL-3R␣ and WT or cysteine mutant h␤c were prepared as described by Jenkins et al. (31) . These were mixed with radiolabeled double-stranded oligonucleotides corresponding to the prolactin-responsive element in the bovine ␤-casein promoter, and EMSA was performed essentially as described by Barry et al. (32) .
RESULTS

Expression of WT or Cysteine Mutant h␤c in Murine CTL-EN
Cells-To introduce WT or cysteine mutant h␤c into CTL-EN cells expressing hIL-3R␣, the cells were infected using 2 cells producing the corresponding RUFHygro retroviruses. The infected CTL-EN cells were selected in hygromycin in IL-2-containing medium, and cell surface expression of h␤c was assessed by FACS analysis. Fig. 1 shows that WT and cysteine mutant ␤c were expressed at comparable levels. Previous studies demonstrated that the cysteine mutations had no effect on the ligand binding in HEK293T cells (22) . To confirm this finding in CTL-EN cells, we performed binding assays with 125 I-IL-3. The results of Fig. 2 show that all receptors, either WT or the cysteine mutants, had similar high affinity binding and were present in similar numbers, in agreement with previous results in HEK293T cells (22) and the FACS analyses of Fig. 1 .
Effects of the h␤c Cysteine Mutations on IL-3-induced Proliferation-
The growth of CTL-EN cells expressing WT h␤c or the cysteine mutants cultured in hIL-3 (10 ng/ml) was monitored over a 3-day period. The results of Fig. 3A show that cells expressing Mc4 and Mc5 mutants did not exhibit detectable growth, whereas cells expressing the Mc7 mutant grew similarly to those expressing WT h␤c. Interestingly, it was found that although most cells expressing Mc4 and Mc5 mutants could not grow or survive in IL-3, a small subset (we estimate Յ1%) of these cells grew out over a period of several weeks from IL-3-containing cultures. To distinguish these subsets, which were maintained in medium containing hIL-3, we will term these cells "IL-3-selected cells," whereas the bulk population of (mutant) h␤c-expressing cells, maintained in IL-2, will hereafter be termed "unselected cells." It was found that the IL-3-selected cells proliferated at similar rates to the cells expressing WT h␤c (Fig. 3B ) and did not grow or survive in medium lacking cytokines (data not shown). Moreover, polymerase chain reaction amplification and sequencing of h␤c from genomic DNA of the IL-3-selected cells confirmed the presence of the cysteine mutations, i.e. these cells were not genetic revertants. 
Cysteine Mutations Mc4 and Mc5 Markedly Impair hIL-3-facilitated Protection against Apoptosis-To
examine whether the Mc4 and Mc5 mutations have an effect on cell survival, unselected CTL-EN cells expressing WT or cysteine mutant h␤c were cultured in different concentrations of IL-3 for 48 h, following which the proportions of apoptotic cells were determined by annexin
Effects of Cysteine Mutations Mc4 and Mc5 on JAK2 and STAT Activation-The activity of JAK2 is believed to be necessary for all the biological functions of IL-3 and GM-CSF (7).
We therefore examined the effects of the Mc4 and Mc5 mutations on JAK2 and STAT activation. In the case of unselected cells, it was found that phosphorylation of JAK2 was observed in cells expressing WT or Mc7 after stimulating the cells with 10 ng/ml hIL-3 but not in cells expressing the Mc4 or Mc5 mutants (Fig. 6A) . Although no JAK2 activation was detected when the cells expressing WT or Mc7 were stimulated with a low concentration of hIL-3 (1 ng/ml), we found that IL-3 at a concentration of 1 ng/ml was able to support proliferation of cells expressing WT or Mc7 (data not shown; see also below).
One class of effectors of JAK2 are the STAT transcription factors, which are phosphorylated and activated by JAK2. We therefore examined nuclear extracts from unselected cells expressing WT or mutant h␤c for the presence of STAT DNA binding activity by performing EMSAs. After stimulation of the cells with 10 ng/ml IL-3, extracts from cells expressing WT or Mc7 contained a protein complex that specifically bound to a ␤-casein oligonucleotide probe containing a DNA-binding site for STATs 1, 3, and 5 (Fig. 6B) . However, no STAT activation was detected in cells expressing the Mc4 or Mc5 mutants (Fig.  6B) after stimulation by IL-3. Weak STAT activation was also detected in cells expressing WT or Mc7 stimulated with 1 ng/ml IL-3. The most likely explanation for this, considering that no JAK2 activation was detected with this concentration of IL-3, is simply that EMSA detection of STAT activity is more sensitive than detection of JAK2 tyrosine phosphorylation.
Because, as mentioned above, a subpopulation of cells expressing the cysteine mutants Mc4 or Mc5 could be selected for growth in IL-3, we investigated whether or not JAK2 and STATs were activated in IL-3-selected cells expressing these mutants. Fig. 6 , C and D, shows that JAK2 and STAT activation was detected following stimulation with IL-3 at 10 ng/ml not only in cells expressing WT or Mc7 but, in contrast to the unselected cells, also in cells expressing Mc4 or Mc5. As for Mc7 and WT, weak activation of STAT but not JAK2 was also detected when a low concentration of IL-3 was used.
Effects of Cysteine Mutations Mc4 and Mc5 on Ras-Raf-MAP Kinase
Pathway-One of the major signaling pathways activated in response to cytokines is the Ras-Raf-MAP kinase pathway (11, 12) . To examine whether the cysteine mutations have an effect on h␤c-mediated activation of Erk1/2 MAP kinases, Western blot analyses of cell lysates from both unselected and IL-3-selected cells with an antibody specific for activated, i.e. phosphorylated, Erk1/2 MAP kinases were conducted. Fig. 7A shows that phosphorylation of Erk1/2 MAP kinases was detected in unselected cells expressing WT or Mc7 mutant h␤c when the cells were stimulated with 1 or 10 ng/ml hIL-3. Moreover, Erk1/2 phosphorylation was also clearly detected when cells expressing Mc4 or Mc5 were stimulated with 10 ng/ml hIL-3, although little or no phosphorylation above background was detected with 1 ng/ml hIL-3. In the case of IL-3-selected cells, activation of Erk1/2 MAP kinases was readily detectable in cells expressing WT and all of the cysteine mutant forms of h␤c, regardless of whether the cells were stimulated with a low or high concentration of hIL-3 (Fig. 7B) .
Effects of Cysteine Mutations Mc4 and Mc5 on AKT Kinase-
The activation of the PI3K and its downstream effector AKT has been shown to promote cell survival and suppress apoptosis (18 -20) . We therefore examined the levels of activated AKT kinase in both unselected and IL-3-selected CTL-EN cells expressing WT or mutant h␤c. Western blot analysis of cell lysates from unselected cells using an antibody specific for phosphorylated AKT showed that AKT was activated in cells expressing WT or Mc7 but not in cells expressing Mc4 or Mc5 following stimulation with IL-3 at either 1 or 10 ng/ml (Fig.  8A) . In contrast, when the IL-3-selected cells were similarly treated and analyzed, activated AKT kinase was detected in cells expressing either WT or any of the mutant forms of h␤c (Fig. 8B) . 
DISCUSSION
We previously showed (28) the presence of IL-3-induced disulfide-linked and non-disulfide-linked heterodimers, suggesting two levels of IL-3R␣ and ␤c interaction, a noncovalent one and one that is mediated by Cys-Cys bridging of the receptors. Furthermore, substitution of alanine for cysteines 86 (Mc4) or 91 (Mc5) abolished disulfide-linked IL-3 receptor dimerization and tyrosine phosphorylation of ␤c subunit but had no effect on high affinity binding between ligand and receptor, nor on IL-3-dependent coimmunoprecipitation of ␣ and ␤ subunits (22) . This suggests that disulfide-linked dimerization is essential for receptor phosphorylation. The present studies were designed to determine whether blocking disulfide-linked dimerization has effects on biological and biochemical functions of the IL-3 receptor. To this end, we utilized populations of (normally) IL-2-dependent CTL-EN cells expressing WT or cysteine mutant forms of h␤c along with hIL-3R␣.
We have shown here that the cysteine mutations Analyses of several key intracellular signaling molecules showed that most of these, JAK2, STATs, and Akt, were not activated in response to IL-3 in unselected cells expressing Mc4 or Mc5 but were activated in the corresponding IL-3-selected populations. Thus triggering of these pathways correlated well with the ability of the cells to proliferate in IL-3; this finding was not totally unexpected since considerable evidence indicates that JAK2 activation is an essential and primary effector of receptor function (7, 33) . More unexpectedly, the Erk1/2 MAP kinases were activated by IL-3 in both populations, although it appeared that higher concentrations may be necessary in the case of the unselected Mc4-or Mc5-expressing cells.
The mation of other studies that dissociate these two properties. Okuda et al. (34) , Itoh et al. (35) , and Guthridge et al. (36) all reported that a mutant of h␤c in which all eight cytoplasmic tyrosines were replaced by phenylalanine could still transduce proliferative signals, albeit less efficiently than WT h␤c. In addition, our own studies with constitutively activated point mutants of h␤c (31) showed that one class of such mutants failed to show detectable tyrosine phosphorylation but still elicited rapid proliferation and activation of JAK2, STATs, and Erk1/2. These results also highlight the possibility that serine/ threonine phosphorylation of h␤c may contribute to some of the activities of the IL-3 receptor.
We previously proposed a model for the activated, disulfidelinked GM-CSF, IL-3, and IL-5 receptor complexes in which the activated receptor consists of two cytokine molecules, two ␣ chains and two ␤c chains, i.e. of two disulfide-linked ␣-␤ dimers (22, 37) . Formation of this hexameric receptor complex would result in juxtaposition of two ␤c molecules with their associated JAK kinases, facilitating JAK2 activation and inducing receptor phosphorylation. This model would explain why the Mc4 and Mc5 mutants, which cannot form disulfide-linked ␣-␤ dimers, are unable to induce JAK2 activation and proliferation in the unselected cells. However, the ability of the IL-3-selected cells expressing Mc4 or Mc5 to proliferate normally and activate JAK2 strongly suggests that there can exist other forms of the activated receptor, in addition to the disulfide-linked complex. As we have suggested for certain constitutive h␤c mutants (23) , it may be that ␣-␤ dimers can be active in some circumstances. Alternatively, the Mc4 and Mc5 mutants may be able to form a spatially "incorrect" non-covalently linked higher order complex in which JAK2 activation does not result in h␤c phosphorylation.
Analyses of intracellular signaling by the cysteine mutant receptors in unselected and IL-3-selected CTL-EN cells strongly supports the essential role of JAK2 activation in the induction of proliferation and an important role in maintaining cell survival. Our data are also consistent with an important role for Akt in IL-3-mediated maintenance of cell viability (19, 21) , since the absence of IL-3-induced activation of Akt in unselected Mc4-or Mc5-expressing cells correlated with markedly increased apoptotic death. More surprising was our finding that IL-3 induced activation of Erk1/2 even in the unselected cells, i.e. in the absence of detectable JAK2 activation. (We believe that assaying JAK2 activation by its tyrosine phosphorylation is relatively insensitive; however, the EMSA detection of STAT activation appears to be a much more sensitive, albeit surrogate, assay. This, too, was negative in the unselected Mc4-or Mc5-expressing cells.) While it is generally thought that JAK2 activation is essential for activation of the Ras/Raf/Erk pathway, the evidence for this, in the case of the GM-CSF/IL-3 receptors, is mostly circumstantial (see "Introduction"), although more direct evidence has been published for other cytokine receptors (38, 39) . However, a mutant of the thrombopoietin receptor, Mpl, has been described which activates Erk1/2 in the absence of detectable JAK or STAT activation, and dominant negative JAK2 only partially inhibited Erk activation by gp130 (40) , supporting the notion that cytokine receptors may be able to activate Erk kinases by a JAK-independent mechanism (41) . The apparently lower sensitivity of Erk1/2 activation to IL-3 in the unselected cells needs further study but is consistent with the utilization of an alternate, less efficient pathway than in IL-3-selected or WT-expressing cells.
The activation of Erk1/2 in unselected Mc4-and Mc5-expressing CTL-EN cells is also interesting in the light of the partial resistance of these cells, in the presence of IL-3, to apoptosis. There are apparently contradictory reports on the importance of Erk1/2 activation in the anti-apoptotic activity of the GMR/IL3R/IL5R system and in hemopoietic cells in general (discussed in Ref. 42 ), but several studies have shown that activation of these molecules can at least contribute to antiapoptotic function (15, 17) . Thus, the ability of Mc4 and Mc5 to promote some survival of the unselected cells may be due, at least in part, to activation of Erk1/2; future studies with specific inhibitors could clarify this issue, but our results nevertheless suggest that the anti-apoptotic activity of IL-3 probably involves multiple pathways (42, 43) .
An intriguing question raised by our present studies relates to the emergence of the IL-3-selected subpopulations of CTL-EN cells expressing Mc4 and Mc5. That is, in what way(s) do the selected cells differ from the bulk of the population? The trivial explanations of genetic reversion or spontaneous factor independence have been ruled out. It is formally possible that culture in IL-3 has selected for a second-site mutation in h␤c that somehow compensates for the Mc4 and Mc5 mutations (without restoring h␤c tyrosine phosphorylation). However the fact that with both Mc4 and Mc5, IL-3-responsive cells grew out in each of two independent experiments suggests it is far more likely that there is an intrinsic difference in the selected cells themselves. One possible explanation is that (i) the selected cells represent those that express the highest levels of a particular accessory signaling molecule and (ii) high levels of this molecule can enhance the efficiency of signaling by an ␣-␤ dimer or non-covalent higher order complex (see above). Although there are no obvious candidates for such a molecule, we note that SH2-B␤ has recently been shown to interact with and enhance activation of JAK2 (44); high levels of a molecule such as this could readily account for the properties of the IL-3-selected cells.
